Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

Tatsuki Uemura; Akio Kimura; Wataru Matsuda; Akiyoshi Hagiwara; Noriko Tanaka

首页> 外文期刊>BMJ Open >Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

【24h】

Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

机译：重组人血栓调节蛋白能否提高严重脓毒性诱导的弥散性血管内凝血患者的生存率：一项单中心，开放标签，随机对照试验

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Abstract Objective To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among patients with severe septic-induced disseminated intravascular coagulation (DIC). Design Single-centre, open-label, randomised controll

机译：摘要目的确定重组人血栓调节蛋白（rhTM）治疗是否能增加严重脓毒性诱导的弥散性血管内凝血（DIC）患者的生存率。设计单中心，开放标签，随机对照

著录项

来源
《BMJ Open》 |2016年第12期|共页
作者
Tatsuki Uemura; Akio Kimura; Wataru Matsuda; Akiyoshi Hagiwara; Noriko Tanaka;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation [J] . Norihisa Yasuda, Koji Goto, Yoshifumi Ohchi, Journal of critical care . 2017,第期

机译：抗凝血酶和重组人血栓调节素组合治疗对严重脓毒症患者的疗效和安全性和弥散血管内凝血
2. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study [J] . Tagami T., Matsui H., Horiguchi H., Journal of thrombosis and haemostasis: JTH . 2015,第1期

机译：败血症相关性弥散性血管内凝血对重症肺炎患者的重组人可溶性血栓调节蛋白和死亡率：一项全国性的观察性研究
3. A randomized, double-blind, placebo-controlled, phase 2b Study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation [J] . VincentJ.-L., RameshM.K., ErnestD., Critical care medicine . 2013,第9期

机译：一项随机，双盲，安慰剂对照的2b期研究，用于评估重组人可溶性血栓调节蛋白ART-123在脓毒症和疑似弥散性血管内凝血患者中的安全性和有效性
4. The effect of Virtual Reality in reducing preoperative anxiety in patients prior to arthroscopic knee surgery: A randomised controlled trial [C] . Anitra Robertson, Riaz Khan, Daniel Fick, IEEE International Conference on Serious Games and Applications for Health . 2017

机译：虚拟现实在关节镜膝关节手术前降低患者术前焦虑的作用：一项随机对照试验
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre open-label randomised controlled trial [O] . Akiyoshi Hagiwara, Noriko Tanaka, Tatsuki Uemura, 2016

机译：重组人血栓调节蛋白能否提高严重脓毒症引起的弥散性血管内凝血患者的生存率：一项单中心开放标签随机对照试验
7. Combined therapy with antithrombin and recombinant human soluble thrombomodulin in patients with severe sepsis and disseminated intravascular coagulation [O] . Hirotaka Sawano, Kazuaki Shigemitsu, Yuichi Yoshinaga, 2013

机译：抗凝血酶和重组人可溶性血栓调节蛋白的组合治疗患者严重脓毒症患者，血管内血管凝固

Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

摘要

著录项

相似文献

相关主题

期刊订阅